Participants began with an average HbA1c level of 8.1%. After three months, people who used Omnipod 5 improved HbA1c by an average of 0.8% compared to those using MDI plus CGM. For those with an HbA1c ...

With a market cap of $18.4 billion, Insulet Corporation (PODD) is a leading developer of innovative insulin delivery systems ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Insulet today announced that it's bringing its automated insulin delivery technology to a range of new geographies.

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Australia, launching soon in Belgium, Canada, and Switzerland. Omnipod 5 is now commercially available in Australia ...

Insulet Corporation’s RADIANT study shows glycaemic improvements with Omnipod 5 automated insulin delivery system: Action, Massachusetts Friday, March 21, 2025, 18:00 Hrs [IST] ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its revolutionary Omnipod 5 ...

“The RADIANT experience showed us that it was easy to implement in pump naïve patients ... for people who require insulin to live and switch from injections to Omnipod 5,” said Insulet ...

“When she got the Omnipod 5, it changed everything.” Unlike traditional insulin pumps that use tubes, the Omnipod 5 adheres directly to the skin and delivers insulin automatically, adjusting every ...